文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Oral Manifestations of COVID-19: Updated Systematic Review With Meta-Analysis.

作者信息

Aragoneses Javier, Suárez Ana, Algar Juan, Rodríguez Cinthia, López-Valverde Nansi, Aragoneses Juan Manuel

机构信息

Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Spain.

Department of Preclinical Dentistry, School of Biomedical Sciences, Universidad Europea de Madrid, Madrid, Spain.

出版信息

Front Med (Lausanne). 2021 Aug 25;8:726753. doi: 10.3389/fmed.2021.726753. eCollection 2021.


DOI:10.3389/fmed.2021.726753
PMID:34513886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8424005/
Abstract

There is increasing evidence for oral lesions and manifestations of COVID-19. The aim of this meta-analysis was to investigate the types of oral manifestations of COVID-19 and their prevalence. PubMed/Medline, Scopus, Web of Science, and Google Scholar databases were used to search for publications on oral manifestations in patients with PCR-confirmed COVID-19. A total of 310 records were selected, and 74 were included. Oral lesions in COVID-19 were classified according to their etiologies, including iatrogenic lesions caused by intubation and opportunistic infections. Of the included studies, 35 reported oral lesions probably caused by severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) infection. Meta-analysis of prevalence data on oral manifestations and aphthous lesions indicated high heterogeneity, while meta-analysis of xerostomia prevalence data revealed a pooled prevalence, with considerable heterogeneity. In conclusion, the meta-analysis yielded high heterogeneity between studies: oral lesions yielded a prevalence of 0.33 (95% CI 0.11-0.60), xerostomia lesions a prevalence of 0.44 (95% CI 0.36-0.52) and aphthous lesions 0.10 (95% CI 0.01-0.24). In addition, a gap in the evidence regarding the prevalence of oral lesions in COVID-19 was identified and the need for further observational studies focusing on this issue and on the causal relationships between oral lesions and COVID-19 was highlighted.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/5a658b56c845/fmed-08-726753-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/4626f1807619/fmed-08-726753-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/c259057f7273/fmed-08-726753-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/608894fb36a6/fmed-08-726753-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/d39e04a43190/fmed-08-726753-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/94ab60da8e2d/fmed-08-726753-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/ff1620074efc/fmed-08-726753-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/7ea2e87df88a/fmed-08-726753-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/5a658b56c845/fmed-08-726753-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/4626f1807619/fmed-08-726753-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/c259057f7273/fmed-08-726753-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/608894fb36a6/fmed-08-726753-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/d39e04a43190/fmed-08-726753-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/94ab60da8e2d/fmed-08-726753-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/ff1620074efc/fmed-08-726753-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/7ea2e87df88a/fmed-08-726753-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/8424005/5a658b56c845/fmed-08-726753-g0008.jpg

相似文献

[1]
Oral Manifestations of COVID-19: Updated Systematic Review With Meta-Analysis.

Front Med (Lausanne). 2021-8-25

[2]
Prevalence of oral manifestations in COVID-19: A systematic review.

Rev Med Virol. 2022-11

[3]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[4]
Estimating the prevalence of oral manifestations in COVID-19 patients: a systematic review.

Osong Public Health Res Perspect. 2023-10

[5]
Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis.

Iran J Med Sci. 2022-1

[6]
nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.

Sci Rep. 2021-6-18

[7]
COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.

Int J Dermatol. 2022-1

[8]
Oral Manifestations in Patients with COVID-19: A 6-Month Update.

J Dent Res. 2021-11

[9]
Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients.

PLoS One. 2021

[10]
Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.

J Dermatol. 2023-5

引用本文的文献

[1]
Comparative analysis of oral manifestations of Covid 19.

J Oral Maxillofac Pathol. 2025

[2]
Painful ulcerations associated with COVID-19 in an adolescent patient: a case report.

Front Dent Med. 2024-8-2

[3]
Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.

Med Princ Pract. 2025

[4]
Oral symptoms potentially associated with mild-to-moderate COVID-19 in tobacco users.

Tob Induc Dis. 2024-5-13

[5]
Prevalence of Oral Manifestations in COVID-19-Diagnosed Patients at a Tertiary Care Hospital in Kerala.

J Maxillofac Oral Surg. 2024-4

[6]
Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells.

Heliyon. 2023-11-20

[7]
Awareness of undergraduate dental students, interns, and freshly graduated dentists about oral manifestation associated with COVID-19.

BMC Oral Health. 2023-12-9

[8]
Estimating the prevalence of oral manifestations in COVID-19 patients: a systematic review.

Osong Public Health Res Perspect. 2023-10

[9]
An Ethical Analysis Regarding the COVID-19 Pandemic Impact on Oral Healthcare in Patients with Mental Disorders.

Healthcare (Basel). 2023-9-19

[10]
Oral lesions in patients with severe COVID-19 in the National Institute of Respiratory Diseases in Mexico: Case series.

J Dent Res Dent Clin Dent Prospects. 2023

本文引用的文献

[1]
Oral and cutaneous manifestations of viral and bacterial infections: Not only COVID-19 disease.

Clin Dermatol. 2021

[2]
COVID-19 and oral lesions, short communication and review.

J Clin Exp Dent. 2021-3-1

[3]
Covid-19 Symptomatic Patients with Oral Lesions: Clinical and Histopathological Study on 123 Cases of the University Hospital Policlinic of Bari with a Purpose of a New Classification.

J Clin Med. 2021-2-13

[4]
Oral manifestations in mild-to-moderate cases of COVID-19 viral infection in the adult population.

Dent Med Probl. 2021

[5]
Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19.

J Dent Res. 2021-5

[6]
Covid-19 and oral diseases: Crosstalk, synergy or association?

Rev Med Virol. 2021-11

[7]
Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients.

J Am Dent Assoc. 2021-3

[8]
Oral manifestations of COVID-19: Brief review.

Dent Med Probl. 2021

[9]
Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases.

J Clin Med. 2021-2-4

[10]
A Systematic Review of Systematic Reviews on the COVID-19 Pandemic.

SN Compr Clin Med. 2021

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索